GlassScriptPhysician profile
Erin C Langan
NPI 1134253958
$1,622.39
in general payments reported to CMS, 2019-2025
27 companies · $548 in 2025
The $548 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $113 · 2021: $131 · 2022: $231 · 2023: $161 · 2024: $226 · 2025: $548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $934.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $934.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $253.75 | 2019-2025 | |
| Davol INC. | $218.31 | 2025 | Arista |
| Astellas Pharma US INC | $124.27 | 2024-2025 | Veozah |
| Coopersurgical, INC. | $108.98 | 2021-2024 | Paragard T 380a, Paragard T 380a |
| Baxter Healthcare | $96.11 | 2019-2025 | Tisseel |
| Organon LLC | $95.10 | 2021-2024 | |
| Smith+Nephew, INC. | $85.31 | 2019-2024 | Pico 7 |
| Therapeuticsmd, INC. | $80.77 | 2019-2020 | |
| Exeltis, USA INC. | $48.58 | 2024-2025 | Slynd |
| Sage Therapeutics, LLC | $48.24 | 2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $48.06 | 2019 | |
| Exact Sciences Corporation | $47.58 | 2025 | Cologuard Collection Kit |
| Shield Therapeutics INC | $46.13 | 2024 | |
| Convatec INC. | $35.21 | 2025 | |
| Sumitomo Pharma America, INC. | $35.04 | 2023-2024 | Myfembree |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma Global Development | $28.48 | 2024 | Veozah |
| Kci USA, INC. | $26.16 | 2020 | |
| Mayne Pharma Commercial LLC | $25.92 | 2023 | |
| Pfizer INC. | $24.29 | 2025 | |
| Boston Scientific Corporation | $23.52 | 2023 | Advantage System |
| Roche Diagnostics Corporation | $22.81 | 2019 | |
| Medtronic, INC. | $21.02 | 2022 | |
| Biogen, INC. | $20.97 | 2022 | |
| Evofem Biosciences, INC. | $20.28 | 2022 | |
| Hologic Sales and Service, LLC | $14.35 | 2020 | |
| Mylan Pharmaceuticals INC. | $11.69 | 2021 | |
| Amag Pharmaceuticals, INC. | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Langan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.